ear prior. This is a clear sign of strength within the company. Compared to other companies in the Pharmaceuticals industry and the overall market, MERCK & CO's return on equity exceeds that of both the industry average and the S&P 500. EFTA00847263 Net operating cash flow has increased to $2,585.00 millio